Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression
Wenjing Su, Hyun Ho Han, Yan Wang, et al.
Cancer Cell (2019) Vol. 36, Iss. 2, pp. 139-155.e10
Open Access | Times Cited: 179

Showing 1-25 of 179 citing articles:

Cancer stem cell–immune cell crosstalk in tumour progression
Defne Bayık, Justin D. Lathia
Nature reviews. Cancer (2021) Vol. 21, Iss. 8, pp. 526-536
Open Access | Times Cited: 383
The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy
Qiyao Yang, Ningning Guo, Yi Zhou, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 10, Iss. 11, pp. 2156-2170
Open Access | Times Cited: 315
Steps in metastasis: an updated review
Jamal Majidpoor, Keywan Mortezaee
Medical Oncology (2021) Vol. 38, Iss. 1
Closed Access | Times Cited: 213
Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt/β‐catenin signaling
Xiaohui Tian, Yuanyuan Wu, Yating Yang, et al.
Molecular Oncology (2019) Vol. 14, Iss. 2, pp. 462-483
Open Access | Times Cited: 176
EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer
Katherine L. Morel, Anjali V. Sheahan, Deborah L. Burkhart, et al.
Nature Cancer (2021) Vol. 2, Iss. 4, pp. 444-456
Open Access | Times Cited: 176
CCL2: An Important Mediator Between Tumor Cells and Host Cells in Tumor Microenvironment
Jiakang Jin, Jinti Lin, Ankai Xu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 122
HIF1α lactylation enhances KIAA1199 transcription to promote angiogenesis and vasculogenic mimicry in prostate cancer
Yongwen Luo, Zhonghua Yang, Ying Yu, et al.
International Journal of Biological Macromolecules (2022) Vol. 222, pp. 2225-2243
Closed Access | Times Cited: 106
Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment
Bo Wu, Xiang Shi, Meixi Jiang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 105
Mechanisms of Polycomb group protein function in cancer
Victoria Parreno, Anne‐Marie Martinez, Giacomo Cavalli
Cell Research (2022) Vol. 32, Iss. 3, pp. 231-253
Open Access | Times Cited: 103
The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 78
The roles of E3 ubiquitin ligases in cancer progression and targeted therapy
Chibuzo Sampson, Qiuping Wang, Wuxiyar Otkur, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 3
Open Access | Times Cited: 70
Single-cell analyses implicate ascites in remodeling the ecosystems of primary and metastatic tumors in ovarian cancer
Xiaocui Zheng, Xinjing Wang, Xi Cheng, et al.
Nature Cancer (2023) Vol. 4, Iss. 8, pp. 1138-1156
Open Access | Times Cited: 62
METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer
Raquel García-Vílchez, Ana M. Añazco-Guenkova, Sabine Dietmann, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 50
LncRNA Malat1 suppresses pyroptosis and T cell-mediated killing of incipient metastatic cells
Dhiraj Kumar, Sreeharsha Gurrapu, Yan Wang, et al.
Nature Cancer (2024) Vol. 5, Iss. 2, pp. 262-282
Closed Access | Times Cited: 27
Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation
Milad Ashrafizadeh, Wei Zhang, Yu Tian, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 1, pp. 229-260
Closed Access | Times Cited: 17
Tumor-intrinsic regulators of the immune-cold microenvironment of prostate cancer
Lourdes Brea, Jindan Yu
Trends in Endocrinology and Metabolism (2025)
Closed Access | Times Cited: 4
Cancer stem cells and niches: challenges in immunotherapy resistance
Yonglong Pan, Chaoyi Yuan, Chenglong Zeng, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Targeting the histone reader ZMYND8 inhibits antiandrogen-induced neuroendocrine tumor transdifferentiation of prostate cancer
Hanling Wang, Sulin Zhang, Qiang Pan‐Hammarström, et al.
Nature Cancer (2025)
Closed Access | Times Cited: 2
Immune escape: A critical hallmark in solid tumors
Keywan Mortezaee
Life Sciences (2020) Vol. 258, pp. 118110-118110
Closed Access | Times Cited: 126
BMI1 Inhibition Eliminates Residual Cancer Stem Cells after PD1 Blockade and Activates Antitumor Immunity to Prevent Metastasis and Relapse
Lingfei Jia, Wuchang Zhang, Cun‐Yu Wang
Cell stem cell (2020) Vol. 27, Iss. 2, pp. 238-253.e6
Open Access | Times Cited: 115
Polycomb group-mediated histone H2A monoubiquitination in epigenome regulation and nuclear processes
Haithem Barbour, Salima Daou, Michael J. Hendzel, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 112
Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistance
Anmbreen Jamroze, Gurkamal Chatta, Dean G. Tang
Cancer Letters (2021) Vol. 518, pp. 1-9
Open Access | Times Cited: 95
T-Cell Infiltration and Adaptive Treg Resistance in Response to Androgen Deprivation With or Without Vaccination in Localized Prostate Cancer
Aleksandar Z. Obradovic, Matthew C. Dallos, Marianna Zahurak, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 13, pp. 3182-3192
Open Access | Times Cited: 92
Biology and therapeutic targeting of tumour‐associated macrophages
Tim Beltraminelli, Michele De Palma
The Journal of Pathology (2020) Vol. 250, Iss. 5, pp. 573-592
Open Access | Times Cited: 76
Understanding and targeting prostate cancer cell heterogeneity and plasticity
Dean G. Tang
Seminars in Cancer Biology (2021) Vol. 82, pp. 68-93
Open Access | Times Cited: 63
Page 1 - Next Page

Scroll to top